Subhajyoti De

Rbhs -Cancer Institute Of New Jersey

$4,216,614

Attributed

$4,216,614

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $790.7K · FY2019–25

$1M$750K$500K$250K$0

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$4,216,614 · 4

By mechanism

R01$1,733,777 · 1

P01$1,079,970 · 1

R35$1,000,875 · 1

R21$401,992 · 1

Top collaborators

No co-investigators on record.

Most similar at Rbhs -Cancer Institute Of New Jersey

Same institution · by research overlap

Hossein Khiabanian$1,928,732
Jian Cao$2,252,466

Others in their field

Other Emerging Leaders on “Malignant Neoplasms”

Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Leonard Freedmand · Leidos Biomedical Research, Inc.$108,968,336
Beverly Hayes · Leidos Biomedical Research, Inc.$98,336,166
Martha Hering · Westat, Inc.$57,098,843

Research focus

Malignant NeoplasmsGenomicsAffectSomatic MutationDna RepairEtiologyAgingPatternMutationResearch PersonnelMaintenanceEpigenomicsDoctor Of PhilosophyInsightPathway InteractionsDefectComputer FrameworkNuclearGenomeDna Sequence AlterationChromatinGenome IntegrityCancer GenomicsGenomic Instability